Nobody starts a medication hoping for side effects. But going in with your eyes open — knowing what's common, what's rare, and what actually works to manage each symptom — makes the experience dramatically more tolerable. The nausea that catches you off guard at 6am is a lot worse than the nausea you expected and prepared for.
So let's lay it all out.
Nausea: the big one
Between 15% and 45% of people taking GLP-1 medications experience nausea, making it the single most reported side effect across every drug in the class. The wide range reflects differences between medications and doses — but regardless of which drug you're on, nausea is the symptom you're most likely to encounter.
A comprehensive analysis of gastrointestinal tolerability across the SURMOUNT-1 through SURMOUNT-4 trials confirmed that nausea peaks during dose escalation periods — the weeks when your dose is being increased — and typically improves significantly once you've been at a stable dose for two to three weeks (Rubino et al., 2025).
What actually helps: eat smaller meals more frequently rather than three large ones. Avoid fatty, greasy, or heavily spiced food during dose adjustment periods — these sit heavy in a stomach that's already emptying slowly. Ginger is genuinely effective, not a folk remedy; ginger tea, ginger chews, or ginger capsules before meals can take the edge off meaningfully. Eat slowly, chew thoroughly, and stay upright for at least 30 minutes after eating.
If nausea is severe enough that you can't keep food or water down for more than 24 hours, that's a call-your-doctor situation, not a ride-it-out situation.
Constipation: more common than people admit
Roughly 15-25% of GLP-1 users experience constipation, making it the second most frequently reported gastrointestinal symptom. People don't talk about it as much as nausea because, well, it's not exactly dinner conversation. But it's a genuine quality-of-life issue that deserves attention.
The mechanism is straightforward. GLP-1 medications slow gastric emptying — that's part of how they work. But the slowdown affects your entire digestive tract, not just your stomach. Combine that with eating less food overall (less bulk moving through the system) and potential dehydration, and constipation is a predictable consequence.
Water is your first line of defence. Genuinely — most people underestimate how much their fluid intake drops when they're eating less. Aim for at least 2-3 litres daily. Add a fibre supplement like psyllium husk. Eat vegetables at every meal. Walk regularly — physical movement stimulates gut motility more than people realise. And consider magnesium citrate, which serves double duty as both a mineral supplement and a gentle natural laxative.
If you haven't had a bowel movement in four or five days, or if you're experiencing severe abdominal pain, contact your doctor.
Fatigue: the early weeks drain
About 10-15% of users report meaningful fatigue, particularly in the first few weeks. You've gone from consuming a certain number of calories daily to consuming significantly less, and your body needs time to adjust its energy systems.
This usually isn't the medication directly causing tiredness — it's the caloric adjustment. Make sure you're eating enough. Extreme restriction stacked on top of GLP-1 appetite suppression creates an energy deficit that leaves you running on empty. Stay hydrated. Prioritise sleep. And consider whether you're getting adequate iron, B12, and other essential micronutrients — deficiencies become more likely when overall food intake drops.
Light exercise, counterintuitively, often improves energy levels during this phase. A 20-minute walk can shift your state more effectively than another hour on the couch.
Hair changes: the anxiety-inducing one
Hair thinning is reported by roughly 3-5% of GLP-1 users in clinical trials, though anecdotal reports in online communities suggest the number may be somewhat higher. A systematic review examining GLP-1 medications and hair loss from a dermatological perspective found that the phenomenon — called telogen effluvium — is primarily associated with rapid weight loss rather than the medication itself (Daneshgaran et al., 2025).
When your body undergoes significant physiological stress — including rapid weight loss by any method — the hair growth cycle can shift. Hair follicles that were in the growth phase move into the shedding phase prematurely. The result is noticeable thinning, usually starting 2-4 months after significant weight loss begins.
The most important intervention is adequate protein intake. Hair is made of protein. Shortchange your protein and your body will prioritise more essential functions. A biotin supplement may help. Get your iron and ferritin levels checked — low iron is a common contributor to hair thinning that's easily corrected. And perhaps most reassuringly: telogen effluvium is almost always temporary. Once weight loss stabilises and nutrition is adequate, most people see their hair return to normal within 6-12 months.
Interestingly, one case report documented actual hair regrowth in a man whose androgenic alopecia improved after starting tirzepatide — likely due to the treatment of underlying insulin resistance (Gordon et al., 2024). The relationship between GLP-1 medications and hair isn't always negative.
Acid reflux and heartburn
Moderately common, especially in people with pre-existing reflux. Slower gastric emptying means food and stomach acid sit together longer, which can increase reflux symptoms.
Don't eat within 2-3 hours of lying down. Elevate the head of your bed slightly. Avoid your known trigger foods. Eat smaller portions. Over-the-counter antacids can manage mild symptoms. If reflux becomes persistent or painful, your doctor may recommend a proton pump inhibitor.
The rare but serious ones
These deserve awareness even though they're uncommon.
Pancreatitis occurs in fewer than 1% of users in clinical trials. A meta-analysis looking specifically at pancreatitis and gallbladder risk with GLP-1 medications found no significant pancreatitis signal, though a modestly increased composite gallbladder risk was observed compared to placebo (Zeng et al., 2023). Symptoms to watch for: severe, persistent abdominal pain radiating to your back, accompanied by nausea and vomiting that feels distinctly different from typical GLP-1 nausea. This requires immediate medical attention.
Gallbladder problems are a known risk with rapid weight loss by any method. Sharp pain in the upper right abdomen, especially after fatty meals, sometimes radiating to the shoulder. If this happens, see your doctor promptly.
Thyroid concerns come from animal studies where GLP-1 medications were associated with thyroid C-cell tumours in rodents. This has not been observed in humans, but all GLP-1 medications carry a boxed warning about it. They're contraindicated in people with personal or family history of medullary thyroid carcinoma. Any new lump in your neck, difficulty swallowing, or persistent hoarseness warrants medical evaluation.
The psychiatric safety question
This gets its own section because it generates genuine anxiety. The most thorough analysis to date — a dedicated post-hoc examination of the STEP 1, 2, 3, and 5 trials — found no increased risk of depression or suicidal ideation with semaglutide compared to placebo. In fact, a small reduction in depressive symptoms was observed (Wadden et al., 2024).
Post-marketing surveillance databases have shown some signals, but these haven't established a causal link, and the FDA/EMA investigations concluded accordingly. We cover this topic in much more depth in our dedicated mental health guide.
The honest summary
Most GLP-1 side effects are gastrointestinal, temporary, and manageable. They're worst during the first few weeks and during dose increases, then tend to improve substantially as your body adjusts. The key is preparation: know what's coming, have your strategies ready, and don't hesitate to slow down the dose escalation if side effects are significantly impacting your daily life.
The goal is sustainable treatment, not suffering through unnecessary discomfort to hit a dose target faster. Talk to your doctor. Adjust the pace if needed. The medication will still work.
Key Studies & References
We base this guide on peer-reviewed clinical research so you can see exactly where the information comes from.
-
Rubino et al. (2025) — Detailed analysis of gastrointestinal tolerability across all four SURMOUNT trials (tirzepatide), confirming that nausea and GI side effects peak during dose escalation and improve with time. Read the study on PubMed
-
Daneshgaran et al. (2025) — Systematic review of "Ozempic face" and GLP-1-related hair and skin changes from a plastic surgery perspective, confirming telogen effluvium is primarily linked to rapid weight loss. Read the study on PubMed
-
Gordon et al. (2024) — Case report showing hair regrowth (androgenic alopecia improvement) in a patient treated with tirzepatide for insulin resistance. Read the case report on PubMed
-
Zeng et al. (2023) — Meta-analysis examining pancreatitis and gallbladder/biliary disease risk with GLP-1 medications: no pancreatitis signal detected, modestly increased composite gallbladder risk. Read the meta-analysis on PubMed
-
Wadden et al. (2024) — Post-hoc psychiatric safety analysis of the STEP 1, 2, 3, and 5 semaglutide trials, finding no increased risk of depression or suicidal ideation. Read the study on PubMed
-
Almansour et al. (2025) — Real-world post-marketing safety analysis using FDA FAERS data (2022-2025) covering dosing errors, injection-site reactions, and gastrointestinal issues. Read the study on PMC
Medical Disclaimer: GLP-1 medications are prescription drugs requiring medical supervision. This guide is for informational purposes only — always consult your healthcare provider about any side effects you experience.